Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients
약물 독성 연구를 위한 분자 네트워킹: COVID-19 환자의 하이드록시클로로퀸 사례
Article
[키워드] addition
adverse effect
adverse effects
adverse event
approach
biological parameter
biological parameters
Cell
cells
clinical trial
Cohort
Combination
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 symptom
COVID-19 symptoms
cytotoxicity
determine
disease
drug
drug metabolism
fatty acids
Fatty liver
fatty liver disease
HCQ
HepaRG
hepatic steatosis
hepatotoxicity
high resolution
Hydroxychloroquine
illness
in vitro
in vitro data
in vivo
induce
Liquid chromatography
mass spectrometry
metabolism
metabolite
modify
molecular
molecular networking
networking
neutral lipid
obese
obese patient
obese patients
outcomes
pathophysiological feature
pathophysiological features
Patient
plasma
Rennes University Hospital
risk factor
steatosis
study drug
These cells
Toxicity
treat
treated
were used
worsened
[DOI] 10.3390/ijms23010082 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23010082 PMC 바로가기 [Article Type] Article